과제정보
This study was supported by a 2022 research grant from Pusan National University Yangsan Hospital. We are grateful to the Springer Nature, Oxford University Press, and Elsevier for their permission to reuse figures.
참고문헌
- Roser M, Ortiz-Ospina E, Ritchie H. Life expectancy [Internet]. Our World in Data; 2013 [updated 2019 Oct; cited 2022 Mar 1]. Available from: https://ourworldindata.org/life-expectancy.
- Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285-9. https://doi.org/10.1007/BF01623184
- Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-39. https://doi.org/10.1359/jbmr.2000.15.4.721
- van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis. 2009;68:99-102. https://doi.org/10.1136/ard.2008.092775
- Smith DP, Enderson BL, Maull KI. Trauma in the elderly: determinants of outcome. South Med J. 1990;83:171-7. https://doi.org/10.1097/00007611-199002000-00010
- von Ruden C, Augat P. Failure of fracture fixation in osteoporotic bone. Injury. 2016;47 Suppl 2:S3-10. https://doi.org/10.1016/S0020-1383(16)47002-6
- Cheung WH, Miclau T, Chow SK, Yang FF, Alt V. Fracture healing in osteoporotic bone. Injury. 2016;47 Suppl 2:S21-6. https://doi.org/10.1016/S0020-1383(16)47004-X
- Xue D, Li F, Chen G, Yan S, Pan Z. Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials. J Orthop Surg Res. 2014;9:45. https://doi.org/10.1186/1749-799X-9-45
- Colon-Emeric C, Nordsletten L, Olson S, et al. Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int. 2011;22:2329-36. https://doi.org/10.1007/s00198-010-1473-1
- Duckworth AD, McQueen MM, Tuck CE, et al. Effect of alendronic acid on fracture healing: a multicenter randomized placebo-controlled trial. J Bone Miner Res. 2019;34:1025-32. https://doi.org/10.1002/jbmr.3679
- Cecilia D, Jodar E, Fernandez C, Resines C, Hawkins F. Effect of alendronate in elderly patients after low trauma hip fracture repair. Osteoporos Int. 2009;20:903-10. https://doi.org/10.1007/s00198-008-0767-z
- Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML. Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am. 2009;34:595-602. https://doi.org/10.1016/j.jhsa.2008.12.011
- Ha KY, Park KS, Kim SI, Kim YH. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing? Osteoporos Int. 2016;27:483-8. https://doi.org/10.1007/s00198-015-3243-6
- Peter B, Pioletti DP, Laib S, et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone. 2005;36:52-60. https://doi.org/10.1016/j.bone.2004.10.004
- Aspenberg P. Bisphosphonates and implants: an overview. Acta Orthop. 2009;80:119-23. https://doi.org/10.1080/17453670902807466
- Tagil M, Annette W, Harding AK, Little D, Toksvig-Larsen S. Enhanced Pin fixation for un-coated standard pins by a single bisphosphonate infusion in hemicallotasis osteotomy. A double-blinded placebo controlled randomized study. Bone. 2008;42(Suppl 1):S87-8. https://doi.org/10.1016/j.bone.2007.12.165
- Friedl G, Radl R, Stihsen C, Rehak P, Aigner R, Windhager R. The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial. J Bone Joint Surg Am. 2009;91:274-81. https://doi.org/10.2106/JBJS.G.01193
- Dhert WJ, Thomsen P, Blomgren AK, Esposito M, Ericson LE, Verbout AJ. Integration of press-fit implants in cortical bone: a study on interface kinetics. J Biomed Mater Res. 1998;41:574-83. https://doi.org/10.1002/(sici)1097-4636(19980915)41:4<574::aid-jbm9>3.0.co;2-9
- Ganz R, Perren SM, Ruter A. [Mechanical induction of bone resorption]. Fortschr Kiefer Gesichtschir. 1975;19:45-8. German.
- Goldhahn J, Feron JM, Kanis J, et al. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int. 2012;90:343-53. https://doi.org/10.1007/s00223-012-9587-4
- Gerstenfeld LC, Sacks DJ, Pelis M, et al. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res. 2009;24:196-208. https://doi.org/10.1359/jbmr.081113
- Adami S, Libanati C, Adachi J, et al. Denosumab administration is not associated with fracture healing complications in postmenopausal women with osteoporosis: results from the FREEDOM trial. J Bone Miner Res. 2010;25(Suppl 1):MO0405. https://doi.org/10.1002/jbmr.5650251305
- Cao Y, Mori S, Mashiba T, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res. 2002;17:2237-46. https://doi.org/10.1359/jbmr.2002.17.12.2237
- Spiro AS, Khadem S, Jeschke A, et al. The SERM raloxifene improves diaphyseal fracture healing in mice. J Bone Miner Metab. 2013;31:629-36. https://doi.org/10.1007/s00774-013-0461-x
- Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;14:960-8. https://doi.org/10.1359/jbmr.1999.14.6.960
- Shibamoto A, Ogawa T, Duyck J, Vandamme K, Naert I, Sasaki K. Effect of high-frequency loading and parathyroid hormone administration on peri-implant bone healing and osseointegration. Int J Oral Sci. 2018;10:6. https://doi.org/10.1038/s41368-018-0009-y
- Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010;25:404-14. https://doi.org/10.1359/jbmr.090731
- Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93:1583-7. https://doi.org/10.2106/JBJS.J.01379
- Huang TW, Chuang PY, Lin SJ, et al. Teriparatide improves fracture healing and early functional recovery in treatment of osteoporotic intertrochanteric fractures. Medicine (Baltimore). 2016;95:e3626. https://doi.org/10.1097/MD.0000000000003626
- Li X, Ominsky MS, Warmington KS, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. 2009;24:578-88. https://doi.org/10.1359/jbmr.081206
- Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P. Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res. 2010;25:2412-8. https://doi.org/10.1002/jbmr.135
- Schemitsch EH, Miclau T, Karachalios T, et al. Placebo-controlled study of romosozumab for the treatment of hip fractures. J Bone Joint Surg Am. 2020;102:693-702. https://doi.org/10.2106/JBJS.19.00790
- Bhandari M, Schemitsch EH, Karachalios T, et al. Romosozumab in skeletally mature adults with a fresh unilateral tibial diaphyseal fracture: a randomized phase-2 study. J Bone Joint Surg Am. 2020;102:1416-26. https://doi.org/10.2106/JBJS.19.01008
- Kim TY, Ha YC, Kang BJ, Lee YK, Koo KH. Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg Br. 2012;94:956-60. https://doi.org/10.1302/0301-620X.94B7.29079
- Amanat N, McDonald M, Godfrey C, Bilston L, Little D. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res. 2007;22:867-76. https://doi.org/10.1359/jbmr.070318
- Hagino H, Sugimoto T, Tanaka S, et al. A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial05. Osteoporos Int. 2021;32:2301-11. Erratum in: Osteoporos Int. 2021;32:2143. https://doi.org/10.1007/s00198-021-05996-2
- Kanis JA, Burlet N, Cooper C, et al.;European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19:399-428. Erratum in: Osteoporos Int. 2008;19:1103-4. https://doi.org/10.1007/s00198-008-0560-z
- Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3-44. Erratum in: Osteoporos Int. 2020;31:209. Erratum in: Osteoporos Int. 2020;31:801. https://doi.org/10.1007/s00198-018-4704-5
- Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31:1-12. Erratum in: Osteoporos Int. 2020;31:797-8. https://doi.org/10.1007/s00198-019-05176-3
- Altintas, F, Ozkut AT, Beyzadeoglu T, Eren A, Guven M. [The effect of risedronate treatment on bone turnover markers in patients with hip fracture]. Acta Orthop Traumatol Turc. 2007;41:132-5. Turkish.
- Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799-809. https://doi.org/10.1056/NEJMoa074941
- Kim K, Won YY, Lee SW, Seo KD. The effect of teriparatide on the hip: a literature review. Hip Pelvis. 2021;33:45-52. https://doi.org/10.5371/hp.2021.33.2.45
- Kim SJ, Park HS, Lee DW, Lee JW. Short-term daily teriparatide improve postoperative functional outcome and fracture healing in unstable intertrochanteric fractures. Injury. 2019;50:1364-70. https://doi.org/10.1016/j.injury.2019.06.002
- Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update. J Clin Endocrinol Metab. 2020;105:dgaa048. https://doi.org/10.1210/clinem/dgaa048
- Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl 1):1-46. https://doi.org/10.4158/GL-2020-0524SUPPL
- Miyakoshi N, Aizawa T, Sasaki S, et al. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab. 2015;33:553-9. https://doi.org/10.1007/s00774-014-0617-3
- Saleh A, Hegde VV, Potty AG, Schneider R, Cornell CN, Lane JM. Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J. 2012;8:103-10. https://doi.org/10.1007/s11420-012-9275-y
- Shi Z, Zhou H, Pan B, et al. Effectiveness of teriparatide on fracture healing: a systematic review and meta-analysis. PLoS One. 2016;11:e0168691. https://doi.org/10.1371/journal.pone.0168691
- van de Laarschot DM, McKenna MJ, Abrahamsen B, et al. Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin Endocrinol Metab. 2020;105:1682-99. https://doi.org/10.1210/clinem/dgz295
- Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG. Stopping denosumab. Curr Osteoporos Rep. 2019;17:8-15. Erratum in: Curr Osteoporos Rep. 2020 Jan 31. https://doi.org/10.1007/s11914-020-00565-8
- Anastasilakis AD, Makras P, Yavropoulou MP, Tabacco G, Naciu AM, Palermo A. Denosumab discontinuation and the rebound phenomenon: a narrative review. J Clin Med. 2021;10:152. https://doi.org/10.3390/jcm10010152